COSMOS Pharmaceutical CorporationTSE: 3349

Consolidated Financial Results for the Fiscal Year Ended May 31, 2026[Japanese GAAP]

· Issued by COSMOS Pharmaceutical Corporation via TDnet

Filed with TSE · · 16 pages · English

On 6ix: 6ix.com/news/consolidated-financial-results-for-the-fiscal-year-ended-may-31-2026japanese-gaap

1. Consolidated Financial Results for the Fiscal Year Ended May 31, 2026 (June 1, 2025 - May 31, 2026) (1) Consolidated Operating Results (% indicates changes from the previous corresponding period.) (Note) Comprehensive income: Fiscal year ended May 31, 2026: ¥32,181 million [3.9%] Fiscal year ended May 31, 2025: ¥30,976 million [26.4%] Diluted Ratio of (2) Consolidated Financial Position Total a

COSMOS Pharmaceutical Corporation on 6ix

Earlier from COSMOS Pharmaceutical

Later from COSMOS Pharmaceutical

All COSMOS Pharmaceutical news releases